Hydrochlorothiazide; Quinapril Hydrochloride Tablet
Category: Cardiovascular
FDA status: To Be Discontinued · Last FDA update: Oct 1, 2025 · First posted: Oct 1, 2025 · 1 manufacturers, 2 listed presentations
As of Oct 1, 2025, the FDA lists Hydrochlorothiazide; Quinapril Hydrochloride Tablet as being discontinued. Of 2 manufacturer presentations, 2 Not specified.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Accuretic, Tablet, 12.5 mg; 10 mg (NDC 0071-3112-23) NDC 0071-3112-23 |
Pfizer Inc. | Not specified | Discontinuation of the manufacture of the drug |
| Accuretic, Tablet, 12.5 mg; 20 mg (NDC 0071-5212-23) NDC 0071-5212-23 |
Pfizer Inc. | Not specified | Discontinuation of the manufacture of the drug |
Related medications in shortage
Other Cardiovascular medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Hydrochlorothiazide; Quinapril Hydrochloride Tablet (FDA data as of Oct 1, 2025). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Hydrochlorothiazide; Quinapril Hydrochloride Tablet. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/hydrochlorothiazide-quinapril-hydrochloride-tablet.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).